Actively Recruiting
TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant
Led by University of California, Davis · Updated on 2026-02-18
200
Participants Needed
1
Research Sites
401 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a comparison of the analgesic efficacy of transversus abdominis plane (TAP) blocks with ropivacaine bolus plus continuous ropivacaine infusion via catheters versus single shot TAP blocks with liposomal bupivacaine.
CONDITIONS
Official Title
TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients ages 18 years or older
- Renal Transplant Recipients
You will not qualify if you...
- Patients less than 18 years of age
- Pregnant Women
- Prisoners
- Opioid Tolerant Patients taking more than 30 mg/day of oral morphine equivalent analgesia
- Patients on Systemic anti coagulation
- Patients unable to provide consent
- Hypersensitivity to amide-type local anesthetic or any component of the drug formula
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California Davis
Sacramento, California, United States, 95817
Actively Recruiting
Research Team
A
Ana Arias, BS
CONTACT
N
Natasha Piniero, BS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here